Mumbai, 19th October 2023 – Boehringer Ingelheim India, in partnership with the Pet Practitioners Association of Mumbai (PPAM), recently held an educational session at Mumbai Public School, Colaba. This session is a part of the month-long ‘Stop Rabies’ initiative in Mumbai. The initiative’s primary goal is to drive anti-rabies vaccination rates among uncared animals, educate children about rabies, and underscore the importance of the relationship between humans and animals and its impact on overall public health.
Over 100 students participated in the educational session. As part of the sessions, students were also provided with an educational kit comprising puzzles, stationery, and a booklet with information on rabies.
The attendees from Boehringer Ingelheim included members from the organisation’s regional executive committee : Tawil Mohammed, Regional Managing Director & Head of Human Pharma, Middle East Turkey and Africa (IMETA), Christoph Raab, Head of Finance and Administration, IMETA, Arif Haq, Head of Legal & Compliance, IMETA. The India leadership team was representred by Gagandeep Singh Bedi, Managing Director and Head of Human Pharma , Dr. Vinod Gopal, Director and Country Head of Animal Health and Priya Chandramohan, Director, Communication. Additionally, Dr. Makarand Chavan represented PPAM.
“The ‘Stop Rabies’ initiative, in collaboration with Boehringer Ingelheim India and PPAM, is a timely response to a pressing need in Mumbai. From the launch we’ve successfully vaccinated over 15000+ dogs. We are determined to continue this momentum and ensure that every uncared-for dog in our city is vaccinated under this initiative,” said Dr. Kalimpasha A. Pathan, General Manager, Veterinary Health Department and Deonar Abattoir, Brihanmumbai Muncipal Corporation.
“The campaign showcases our unwavering commitment to sustainability within the ‘More Health’ pillar, an essential element of our ‘Sustainable Development – For Generations’ framework. At Boehringer Ingelheim, we believe in ‘One Health’ for the planet, animals, and humans, and this initiative is a step towards that vision,” said Tawil Mohammed, Regional Managing Director & Head of Human Pharma, IMETA. “It was energizing to join the young minds and witness their eagerness to learn about the human animal bond”, he added.
“Rabies awareness is not just a medical concern, but a societal one. Our collaboration with PPAM and BMC is a reflection of our dedication to creating a safer, more informed community. Awareness is the first step towards building a healthier society and it starts by educating the young minds who will play an important role in the years to come,” said Gagandeep Singh Bedi, Managing Director and Head of Human Pharma at Boehringer Ingelheim India.
